Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H20N2O5.3H2O |
| Molecular Weight | 458.4611 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.CCC(=O)O[C@]1(CC)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC=CC5=C4)C2=O
InChI
InChIKey=IYMREUZGKUWKHF-AQUVTFJZSA-N
InChI=1S/C23H20N2O5.3H2O/c1-3-19(26)30-23(4-2)16-10-18-20-14(9-13-7-5-6-8-17(13)24-20)11-25(18)21(27)15(16)12-29-22(23)28;;;/h5-10H,3-4,11-12H2,1-2H3;3*1H2/t23-;;;/m0.../s1
DescriptionCurator's Comment: Not to be confused with a CD38 inhibitor CZ-48 (https://www.ncbi.nlm.nih.gov/pubmed/31128467)
Curator's Comment: Not to be confused with a CD38 inhibitor CZ-48 (https://www.ncbi.nlm.nih.gov/pubmed/31128467)
Camptothecin-20(S)-O-propionate (CZ48) is a prodrug of camptothecin, an alkaloid isolated from the Chinese tree Camptotheca acuminata, with potential antineoplastic activity. Upon entry into cells, camptothecin-20(S)-O-propionate is hydrolyzed by esterases into the active form camptothecin. Camptothecin selectively stabilizes topoisomerase I-DNA covalent complexes, thereby inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when encountered by the DNA replication machinery. CZ48 is being investigated in clinical trials for the treatment of advanced solid tumors and lymphomas.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1147090-70-7
Created by
admin on Wed Apr 02 10:20:47 GMT 2025 , Edited by admin on Wed Apr 02 10:20:47 GMT 2025
|
PRIMARY | |||
|
TR4HR67FMA
Created by
admin on Wed Apr 02 10:20:47 GMT 2025 , Edited by admin on Wed Apr 02 10:20:47 GMT 2025
|
PRIMARY | |||
|
25263729
Created by
admin on Wed Apr 02 10:20:47 GMT 2025 , Edited by admin on Wed Apr 02 10:20:47 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
